Keywords: Chronic granulomatous disease; dihydrorhodamine-1,2,3 assay; CYBB; CYBA; NCF1; NCF2; nicotinamide dinucleotide phosphate reduced oxidase; mean fluorescence intensity; stimulation index; AR; Autosomal recessive; A22R; A22 CGD with residual oxidase activity